Stacy M. Goins

Stacy M. Goins

Auto-generated profile, based on publicly available information

Stacy M. Goins

Department of Radiology, Duke University Medical Center, 2301 Erwin Road Box 3808, Durham, NC, 27710, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2023 in Radiology
Verified
Journal Article
Closed access
SGStacy M. Goins
Stacy M. Goins
HJHanyu Jiang
Hanyu Jiang
CPChristian B. van der Pol
Christian B. van der Pol
JSJean-Paul Salameh
Jean-Paul Salameh
ELEric Lam
Eric Lam
MBMustafa R. Bashir
Mustafa R. Bashir
Background A simplification of the Liver Imaging Reporting and Data System (LI-RADS) version 2018 (v2018), revised LI-RADS (rLI-RADS), has been proposed for imaging-based diagnosis of hepatocellular carcinoma (HCC). Single-site data suggest that rLI-RADS category 5 (rLR-5) improves sensitivity while maintaining positive predictive value (PPV) of the LI-RADS v2018 category 5 (LR-5), which indicates definite HCC. Purpose To compare the diagnostic performance of LI-RADS v2018 and rLI-RADS in a multicenter data set of patients at risk for HCC by performing an individual patient data meta-analysis. Materials and Methods Multiple databases were searched for studies published from January 2014 to January 2022 that evaluated the diagnostic performance of any version of LI-RADS at CT or MRI for diagnosing HCC. An individual patient data meta-analysis method was applied to observations from the identified studies. Quality Assessment of Diagnostic Accuracy Studies version 2 was applied to determine study risk of bias. Observations were categorized according to major features and either LI-RADS v2018 or rLI-RADS assignments. Diagnostic accuracies of category 5 for each system were calculated using generalized linear mixed models and compared using the likelihood ratio test for sensitivity and the Wald test for PPV. Results Twenty-four studies, including 3840 patients and 4727 observations, were analyzed. The median observation size was 19 mm (IQR, 11-30 mm). rLR-5 showed higher sensitivity compared with LR-5 (70.6% [95% CI: 60.7, 78.9] vs 61.3% [95% CI: 45.9, 74.7]; P < .001), with similar PPV (90.7% vs 92.3%; P = .55). In studies with low risk of bias (n = 4; 1031 observations), rLR-5 also achieved a higher sensitivity than LR-5 (72.3% [95% CI: 63.9, 80.1] vs 66.9% [95% CI: 58.2, 74.5]; P = .02), with similar PPV (83.1% vs 88.7%; P = .47). Conclusion rLR-5 achieved a higher sensitivity for identifying HCC than LR-5 while maintaining a comparable PPV at 90% or more, matching the results presented in the original rLI-RADS study. © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Sirlin and Chernyak in this issue.

1 May 2023 in Radiology
Verified
Journal Article
Closed access
SGStacy M. Goins
Stacy M. Goins
RARobert G. Adamo
Robert G. Adamo
ELEric Lam
Eric Lam
ACAndreu F. Costa
Andreu F. Costa
CPChristian B. van der Pol
Christian B. van der Pol
MBMustafa R. Bashir
Mustafa R. Bashir

1 December 2023 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Open access
SGStacy M. Goins
Stacy M. Goins
HJHanyu Jiang
Hanyu Jiang
CPChristian B. van der Pol
Christian B. van der Pol
JSJean‐Paul Salameh
Jean‐Paul Salameh
ELEric Lam
Eric Lam
MBMustafa R. Bashir
Mustafa R. Bashir
Background: LI‐RADS version 2018 (v2018) is used for non‐invasive diagnosis of hepatocellular carcinoma (HCC). A recently proposed modification (known as mLI‐RADS) demonstrated improved sensitivity while maintaining specificity and positive predictive value (PPV) of LI‐RADS category 5 (definite HCC) for HCC. However, mLI‐RADS requires multicenter validation.Purpose: To evaluate the performance of v2018 and mLI‐RADS for liver lesions in a large, heterogeneous, multi‐national cohort of patients at risk for HCC.Study Type: Systematic review and meta‐analysis using individual participant data (IPD) [Study Protocol: https://osf.io/duys4].Population: 2223 observations from 1817 patients (includes all LI‐RADS categories; females = 448, males = 1361, not reported = 8) at elevated risk for developing HCC (based on LI‐RADS population criteria) from 12 retrospective studies.Field Strength/Sequence: 1.5T and 3T; complete liver MRI with gadoxetate disodium, including axial T2w images and dynamic axial fat‐suppressed T1w images precontrast and in the arterial, portal venous, transitional, and hepatobiliary phases. Diffusion‐weighted imaging was used when available.Assessment: Liver observations were categorized using v2018 and mLI‐RADS. The diagnostic performance of each system's category 5 (LR‐5 and mLR‐5) for HCC were compared.Statistical Tests: The Quality Assessment of Diagnostic Accuracy Studies version 2 (QUADAS‐2 was applied to determine risk of bias and applicability. Diagnostic performances were assessed using the likelihood ratio test for sensitivity and specificity and the Wald test for PPV. The significance level was P < 0.05.Results: 17% (2/12) of the studies were considered low risk of bias (244 liver observations; 164 patients). When compared to v2018, mLR‐5 demonstrated higher sensitivity (61.3% vs. 46.5%, P < 0.001), similar PPV (85.3% vs. 86.3%, P = 0.89), and similar specificity (85.8% vs. 90.8%, P = 0.16) for HCC.Data Conclusion: This study confirms mLR‐5 has higher sensitivity than LR‐5 for HCC identification, while maintaining similar PPV and specificity, validating the mLI‐RADS proposal in a heterogeneous, international cohort.Level of Evidence: 3Technical Efficacy: Stage 2

25 January 2024 in HPB
Verified
Journal Article
Closed access
KRKristen E. Rhodin
Kristen E. Rhodin
SGStacy Goins
Stacy Goins
RKRyan Kramer
Ryan Kramer
AEAustin M. Eckhoff
Austin M. Eckhoff
GHGarth Herbert
Garth Herbert
MLMichael Lidsky
Michael Lidsky

5 October 2024 in Respiratory Medicine
Verified
Journal Article
Closed access
MWMadison Kocher Wulfeck
Madison Kocher Wulfeck
DMDavid G. Mummy
David G. Mummy
SZShuo Zhang
Shuo Zhang
DKDiana Kadi
Diana Kadi
SGStacy Goins
Stacy Goins
JMJoseph G. Mammarappallil
Joseph G. Mammarappallil

15 April 2024 in Journal of Surgical Research
Verified
Journal Article
Closed access
SGStacy M. Goins
Stacy M. Goins
STSteven Thornton
Steven Thornton
EHElizabeth Horne
Elizabeth Horne
BHBrooke Hoehn
Brooke Hoehn
EBErin Brush
Erin Brush
ETElisabeth Tracy
Elisabeth Tracy